TECSYS gets love from Gartner, Industrial Alliance


Industrial Alliance Securities analyst Steve Li says there are many reasons to remain bullish about TECSYS (TSX:TCS). In a research update to clients this morning, Li maintained his “Strong Buy” rating and $10.50 one-year target on TECSYS, implying a return of 33.2% at the time of publication. Yesterday, TECSYS announced it had been granted patent […]

Tecsys gets price target raise at Paradigm

Paradigm Capital analyst Gabriel Leung says Tecsys is pursuing a "very significant" market opportunity in the healthcare vertical.

Paradigm analyst Gabriel Leung says Tecsys’s (TSX:TCS) most recent quarterly results confirm his bullish take on the company’s prospects. Yesterday, Tecsys reported its Q1, 2015 results. The company earned $343,000 on revenue of $13-million, up 23% from the $10.6-million topline the company posted in the same period last year. “This quarter we further extended our […]

Tecsys’s leadership role in healthcare validated by new contracts, says PI


Three new contracts validate Tecsys’s (TSX:TCS) leadership role in providing supply chain solutions in the healthcare market, says PI analyst Pardeep Sangha. Yesterday, Tecsys announced it had added three “major” health systems as customers. CFO Berty Ho-Wo-Cheong commented on the development. “The rapid rate of change health care organizations are facing has driven the adoption […]

TECSYS has double-digit upside, says Cantor Fitzgerald Canada


A number of catalysts are lined up that could drive growth for TECSYS (TSX:TCS), says Cantor Fitzgerald Canada analyst Justin Kew. In a research report to clients yesterday, Kew initiated coverage of TECSYS with a “Buy” rating and an $8.50 one-year target. The analyst says the company enjoys a stable recurring revenue model, an industry […]

Paradigm launches coverage of Tecsys with a Buy rating, $10.00 target

Public Law 113-54, which was signed into law by President Obama last November, establishes a national track and trace system for prescription medication that could accelerate an upgrade cycle of technology throughout the healthcare supply chain, says Paradigm Capital analyst Gabriel Leung.

There is a multi-billion dollar market opportunity in automating the healthcare supply chain and Tecsys (TSX:TCS) is positioned to grab a share of it, says Paradigm Capital analyst Gabriel Leung. In a research report to clients this morning, Leung initiated coverage of Tecsys with a “Buy” rating and a one-year target of $10.00, implying a […]

“Strong Buy” TECSYS gets price target raise from Industrial Alliance


Industrial Alliance analyst Steve Li says he doesn’t see many synergies in TECSYS’ (TSX:TCS) latest acquisition, but he does see “significant” cross selling opportunities. On May 29th, TECSYS announced it had signed an agreement to buy all the shares of of Logi-D Holding, a provider of point-of-use technology for supply chain automation servicing hospitals and […]

TECSYS is undervalued, says PI analyst Pardeep Sangha


TECSYS’s (TSX:TCS) second straight quarter of record revenue is the quickest way to see that it is gaining traction, but scratching the surface reveals that the company is capitalizing on longer industry trends, says PI analyst Pardeep Sangha. Last Thursday, TECSYS reported its Q3, 2014 results. The company earned $467,000, or four cents per share, […]

Ahead of earnings, Steve Li maintains Top Pick rating on Tecsys

Tecsys CEO Peter Brereton: "We believe that we have the best supply chain execution suite on the market today and the market is beginning to agree with us."

Tomorrow morning Tecsys (TSX:TCS) will report its Q2, 2013 results. The company is coming off Q1 results, reported September 6th, that sparked a rally in its shares. Tecsys’s revenue climbed by 28% to $11.5-million and the company’s board declared a semi-annual dividend of $0.035 per share CEO Peter Brereton, said of those results: “We believe […]

Industrial Alliance analyst Li maintains Top Pick rating on Tecsys

The final scene from Raiders of the Lost Ark. Supply chain management has come a long way since the days of Indiana Jones.

Tecsys (TSX:TCS) last week completed a $10-million financing with the National Bank of Canada. The financing consists of a five-year $5.0-million term loan and a $5.0-million operating line of credit. Tecsys CEO Peter Brereton said the capital will be used to help fund expansion: “Over the last 18 months we have experienced a significant increase […]